Trials / Completed
CompletedNCT05723016
Anti-Müllerian Hormone and Embryo Aneuploidy
Serum Anti-Müllerian Hormone Levels and Its Association With Aneuploidy Rates in Human Blastocysts
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (actual)
- Sponsor
- Clinica de la Mujer Medicina Reproductiva, Chile · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to determine is there an association between the rates of aneuploidy and the different ranges of serum Antimullerian hormone (AMH) levels. Retrospective, single-centre study of patients undergoing IVF and preimplantation genetic testing with aneuploidy at the blastocyst stage between January 2018 and December 2022.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | preimplantation genetic test for aneuploidies (PGT-a) | preimplantation genetic test for embryo aneuploidies after IVF |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2023-02-10
- Last updated
- 2023-02-10
Locations
1 site across 1 country: Chile
Source: ClinicalTrials.gov record NCT05723016. Inclusion in this directory is not an endorsement.